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Abstract 
Aims.  The aim of this study was to reanalyze the data from Cuijpers et al.’s (2018) meta-
analysis, to examine Eysenck’s claim that psychotherapy is not effective.  Cuijpers et al., after 
correcting for bias, concluded that the effect of psychotherapy for depression was small 
(standardized mean difference, SMD, between 0.20 and 0.30), providing evidence that 
psychotherapy is not as effective as generally accepted.   
Methods.  The data for this study were the effect sizes included in Cuijpers et al. (2018).  We 
removed outliers from the data set of effects, corrected for publication bias, and segregated 
psychotherapy from other interventions. In our study, we considered wait-list (WL) controls as 
the most appropriate estimate of the natural history of depression without intervention.  
Results.  The SMD for all interventions and for psychotherapy compared to WL controls was 
approximately 0.70, a value consistent with past estimates of the effectiveness of psychotherapy.  
Psychotherapy was also more effective than care-as-usual (SMD = 0.31) and other control group 
(SMD = 0.43). 
Conclusions.  The reanalysis reveals that psychotherapy for adult patients diagnosed with 
depression is effective. 
Keywords: psychotherapy effectiveness, depression, Eysenck, meta-analysis, natural history
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Those who cannot remember the past are condemned to repeat it.  
–George Santayana 
 
Literature and philosophy both allow past idols to be resurrected with a frequency which would 
be truly distressing to a sober scientist. 
–Morris Raphael Cohen 
 
In the 1950s and 1960s Eysenck made some claims about the effectiveness of 
psychotherapy (Eysenck, 1952, 1961, 1966).  Our collective memories of the specific claims 
made by Eysenck have diminished over time and we seem to be left with the simple conclusion 
that Eysenck claimed that psychotherapy was ineffective (Wampold, 2013; Wampold & Imel, 
2015).  Recently Cuijpers, Karyotaki, Rejinders, and Ebert (2018) summarized Eysenck’s claims 
by noting, “He [Eysenck] suggested that psychotherapies are not effective in the treatment of 
mental disorders (Eysenck, 1952)” (p. 1).  It is important to know whether psychotherapy is 
effective or not. However, to make any statement about Eysenck and his claims, one has to 
understand exactly what he claimed and the bases on which he made his claims.  We begin by 
reviewing what Eysenck had to say about the effects of psychotherapy.     
 Based on a review of the research available at the time, Eysenck indeed did conclude that 
psychotherapy was not effective: 
A survey was made of reports on the improvement of neurotic patients after 
psychotherapy, and the results compared with the best available estimates of recovery 
without benefit of such therapy. The figures fail to support the hypothesis that 
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psychotherapy facilitates recovery from neurotic disorder. (emphasis added; Eysenck, 
1952, p. 323) 
When untreated neurotic control groups are compared with experimental groups of 
neurotic patients treated by means of psychotherapy, both groups recover to 
approximately the same extent (emphasis added, Eysenck, 1961, p. 719).  
To be clear about Eysenck’s claim about the ineffectiveness of psychotherapy, he was comparing 
the effects of psychotherapy to those patients who did not receive any treatment.  
 It is important to note that Eysenck was not simply impugning the absolute effectiveness 
of psychotherapy, he was at the same time concluding that one form of psychotherapy was 
effective and that other therapies were unscientific and ineffective.  (viz., behavior therapy; 
Eysenck, 1961; see Wampold, 2013; Wampold & Imel, 2015),   
 Given the distinction among various psychotherapies, any examination of Eysenck’s 
claims must consider what is and what is not psychotherapy.  Eysenck was very careful to define 
psychotherapy:     
1. There is an interpersonal relationship of a prolonged kind between two or more people. 
2. One of the participants has had special experience and/or has received special training 
in the handling of human relationships. 
3. One or more of the participants have entered the relationship because of a felt 
dissatisfaction with their emotional and/or interpersonal adjustment. 
4. The methods used are of a psychological nature, i.e., involve such mechanisms as 
explanation, suggestion, persuasion, and so forth. 
5. The procedure of the therapist is based upon some formal theory regarding mental 
disorder in general, and the specific disorder of the patient in particular. 
Psychotherapy     p. 5 
 
6. The aim of the process is the amelioration of the difficulties which cause the patient to 
seek the help of the therapist. (Eysenck, 1961, p. 698). 
Eysenck’s definition of psychotherapy is in accord with most definitions of 
psychotherapy, which emphasize that an interpersonal relationship is at the heart of the endeavor. 
(e.g., Wampold & Imel, 2015) 
Eysenck’s claims created controversy as well as angst, among mental health professionals 
as well as the public.  There were articles rebutting Eysenck’s conclusions and rejoinders, 
creating a contentious interchange (for a summary see Glass, 2015; Glass & Kliegl, 1983; 
Wampold, 2013; Wampold & Imel, 2015).  The debate about Eysenck’s claims led to a 
proliferation of randomized clinical trials examining both the absolute efficacy of psychotherapy 
(i.e., the effects of psychotherapy versus natural history) and the relative efficacy of various 
treatments (i.e., the relative effects of different therapies; Wampold, 2013; Wampold & Imel, 
2015). In the late 1970s Mary Lee Smith and Gene Glass (Smith & Glass, 1977; Smith, Glass, & 
Miller, 1980) conducted a comprehensive meta-analysis of controlled studies of psychotherapy 
and found that psychotherapy was indeed effective, with a standardized mean difference (SMD) 
treated and untreated patients of approximately 0.70, a relatively large effect.  Of course, 
Eysenck disputed these results by suggesting that meta-analyses ignored problems with the 
primary studies, such as the heterogeneity of included studies (“apples and oranges” problem) 
(Eysenck, 1978, 1984, 1995).  However, several re-analyses of Smith and Glass and additional 
meta-analyses have established an SMD of approximately 0.70, although this varies somewhat 
depending on the problem being treated (see Wampold & Imel, 2015).   
Recently, Cuijpers and colleagues (2018) addressed several of the problems mentioned 
by Eysenck (and others) by examining the effects of interventions for a particular disorder, 
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namely depression, considering various factors that might bias the estimates.  In their article a 
reassessment of the effects of psychotherapy for adult depression, they claimed, much in the way 
that Eysenck did, that there is insufficient evidence to declare that psychotherapy is effective: 
These results suggest that the effects of psychotherapy for depression are small, above the 
threshold that has been suggested as the minimal important difference in the treatment of 
depression, and Eysenck was probably wrong. However, this is still not certain because 
we could not adjust for all types of bias. (p. 1)… [and] the possibility that 
psychotherapies do not have effects that are larger than spontaneous recovery cannot be 
excluded.” (p. 7).  
In this article we address Cuijpers et al.’s (2018) claims and show that a different 
understanding of Eysenck’s conjectures produces an estimate of effectiveness for psychotherapy 
for depression that closely approximates what has been found previously. 
A Reanalysis of Cuijpers et al. (2018) 
The goal of Cuijpers et al. (2018) was to revisit Eysenck’s conclusion that psychotherapy 
was not effective by meta-analytically examining the corpus of studies comparing an 
intervention for adults with depression to a control group and correcting obtained effects for bias 
of various types.  Of course, as meta-analytic methods improve, it is commendable to scrutinize 
prior conclusions in light of the best available methods.   
Cuijpers et al. (2018) examined 369 effects produced by studies that compared 
interventions for depression to a control group.  The overall effect for these interventions was an 
SMD of 0.70 suggesting that Eysenck’s conclusions were in fact incorrect Q.E.D.  But Cuijpers 
et al. claimed that this estimate was biased and when the effects were corrected for these biases 
the “true” effect is between 0.2 and 0.3, casting some doubt on whether Eysenck’s conclusions 
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were truly incorrect. However, Cuijpers et al.’s conclusions depend on several methodological 
decisions that need to be re-examined.  In this article, we examine several of their decisions and 
then reanalyze their data with decisions that we contend are more in line with Eysenck’s 
conjectures. 
Choice of Control Group 
 The corpus of studies in Cuijpers et al. (2018) included three types of control groups: 
waiting list (WL, k = 159), care-as-usual (CAU, k = 144), and “other” (k = 66).1  Unfortunately 
no definition of these types of control groups was presented and no methods for making this 
determination were provided (e.g., coding procedures, interrater agreement, etc.). What is most 
important is that Cuijpers considered WL controls as biased and excluded studies using WL 
when estimating the true effect of psychotherapy.  This is a decision that results in a significant 
decrease in the estimates of psychotherapy effectiveness, and one which is questionable.  We 
examine each of these types of control groups, noting the questions that each is able to address. 
 Waiting-List Controls.  WL controls contain patients who are told that during the 
treatment phase they will receive no treatment as part of the study but that after the treatment 
period, if they choose to, they will receive one of the experimental treatments.  To be clear, no 
treatment is provided to the patients and this type of control group is thought to be a means to 
estimate the natural history of the disorder (Stegenga, Kamphuis, King, Nazareth, & Geerlings, 
2012; Wampold, Minami, Tierney, Baskin, & Bhati, 2005).  If we consider that Eysenck was 
focusing on the effects of psychotherapy compared to recovery without psychotherapy, it would 
seem that WL is an appropriate control group as it compares the outcome of psychotherapy to an 
estimate of natural course of the disorder.   
                                                
1 There was a discrepancy between Table 1 of Cuijpers et al.’s (2018) manuscript and the Appendix C in 
Supplemental materials for WL (k = 159 v. 150, respectively) and CAU (k = 144 v. 153, respectively), which has 
been resolved by P. Cuijpers (personal communication, April, 20th, 2018)   
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 There may well be methodological problems with WL controls.  WL patients may 
actually improve during the study period because they became remoralized by anticipation of 
being included in a state-of-the-art treatment, which might not be obtainable elsewhere, in 15 or 
so weeks (Frank & Frank, 1991).  There is evidence that patients improve from when they make 
an appointment to receive services and when they present for such services (Frank & Frank, 
1991).  Indeed, WL patients in clinical trials for depression improve quite dramatically during 
the waiting period; the effect for patients on WL in RCTs for depression from beginning of the 
waiting period to the end of the waiting period is approximately 0.40 (Minami, Wampold, Serlin, 
Kircher, & Brown, 2007; see also Posternack & Miller, 2001).  WL patients may improve as a 
function of being included in the trial and therefore the use of WL controls may underestimate 
the effects of psychotherapy. 
 On the other hand, patients might feel demoralized by not being selected to receive 
treatment immediately: “Nothing good ever happens to me.  I can’t even get selected to receive 
treatment now.”  This is the resentful demoralization threat to validity (Shadish, Cook, & 
Campbell, 2002).  However, there is little evidence that patients on the WL in clinical trials 
suffer from resentful demoralization.  Of course, many patients in routine clinical care are placed 
on waiting lists until services are available. Ahola et al. (2017) studied patients on waitlists and 
concluded, “Scheduled waiting should be regarded as a preparatory treatment and not as an inert 
nontreatment control” (p. 611).  
 Cuijpers et al. (2018) chose to question WL as a control group and exclude studies that 
used WL controls to estimate the “true” effects of psychotherapy: 
Waiting list control groups may stimulate patients to do nothing about their problems 
because they will get a treatment after the waiting period. Recent meta-analyses suggest 
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that waiting lists may be a nocebo, and artificially inflate the effect sizes of therapies 
(Furukawa et al. 2014). (emphasis added, p. 2). 2  
 To be clear, Cuijpers et al.’s (2018) claim is that WL is inappropriate because it might 
induce patients not to seek help.  That is, patients on WL are purported to avoid seeking therapy 
or any other type of external help.  Consequently, according to this view, WL patients represent 
the population of depressed patients not receiving treatment, which is exactly the control that 
should be used to determine whether a treatment is superior to spontaneous recovery without 
treatment.  The Eysenckian conjecture that psychotherapy is not more effective than no treatment 
would suggest that WL control is a suitable, if not the suitable, hypothesis-driven control group.     
  What is the best way to empirically determine whether WL is biased?   Logically one 
could compare WL control patients with no treatment (NT) controls.  But how would that work?  
First, NT controls are unethical as one cannot deny patients with mental disorders treatment and 
that is the reason WL controls are used in lieu of NT controls.  Second, NT patients would most 
likely experience effects of being included in a trial but be denied any treatment at all.  They 
might be discouraged and deteriorate as a result or they might seek alternate treatment and 
improve—who knows?   
 Cuijpers et al.’s (2018) attribution of bias for WL controls rests on purported evidence 
that WL cause patients to deteriorate relative to NT patients.  But how is that known given that it 
is unethical to deny treatment to patients with mental health disorders who are seeking 
treatment?  The meta-analysis cited by Cuijpers et al. that claimed WL artifactually causes 
deterioration (viz., Furukawa et al., 2014) is a network meta-analysis that involved clinical trials 
                                                
2 A nocebo is a treatment without active ingredients (e.g., inert pill, sham procedures) that results in increased 
symptoms due to expectations created that the nocebo will be harmful, usually through instructions (Benedetti, 
2014; Miller, Colloca, & Kaptchuk, 2009).  Clearly, patients on WL are not induced to expect deterioration in this 
condition, so even if patients deteriorate as a result of being on the WL, WL is not a nocebo.  There is a difference 
between something that is harmful and a nocebo. 
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of CBT against various controls in the treatment of depression.  A closer look showed that this 
meta-analysis contained 13 comparisons (from only 6 separate trials) with NT controls.  
However, none of the studies using an NT control involved patients seeking treatment for 
depression.  The patients in studies with NT controls were college students selected for study 
(not seeking help for depression) or community members identified through screening.  Most, 
although not all, were mildly to moderately depressed and all were not seeking treatment for 
depression.  It is well established that seeking relief for distress is a vital factor for response to 
placebo (Price, Finniss, & Benedetti, 2008).  Interventions in NT trials were more similar to 
prevention programs than treatment programs and many NT studies did not involve 
psychotherapy according to Eysenck’s definition.  Prevention programs and programs for those 
not seeking treatment typically are ineffective (Lilienfeld, 2007; Wampold & Imel, 2015). 
Consequently, it is understandable that the effects of CBT versus NT would be rather small. In 
the NT study that contributed more than half of all participants in NT comparisons in the 
Furukawa et al. meta-analysis (viz., Dowrick et al., 2000), difference of intervention versus NT 
was only SMD = 0.169, suggesting that the treatments employed were only marginally helpful 
for participants. Of course, in the framework of Furukawa et al.’s network meta-analysis, these 
small treatment effects contribute to the impression of more change for participants in NT than in 
WL. 
On the other hand, the CBT versus WL in the Furukawa et al. (2014) meta-analysis 
included studies of patients seeking treatment for depression and it is not surprising that there 
were larger effects in these studies.  The conclusion that WL is a “nocebo” is due to the fact that 
the CBT versus NT prevention studies showed smaller effects than the CBT versus WL 
treatment studies, despite that the studies in these two comparisons were markedly different. 
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Making inferences about the relative effectiveness of treatments or control groups (here WL 
versus NT) from network meta-analyses in lieu of examining direct comparisons often leads to 
erroneous conclusions (see e.g., Del Re, Spielmans, Flückiger, & Wampold, 2013; Jansen & 
Naci, 2013; Wampold et al., 2017; Wampold & Serlin, 2014; Wartolowska et al., 2014), 
especially when, as in Furukawa et al, the consistency of indirect estimates with direct estimates 
cannot be assured (none of the trials directly compared NT and WL controls). Thus, the results of 
this meta-analysis do not provide persuasive evidence that WL is an inappropriate control. 
Moreover, Furukawa et al. reported that the difference between NT and WL was not significantly 
different when publication bias was considered.   
 Given the problematic nature of the Furukawa et al. (2014) meta-analysis and the other 
evidence, we contend that WL is indeed an appropriate control group to address Eysenck’s 
conjecture that psychotherapy is not more effective than no treatment.   
 Care as Usual.  To estimate the “true” effects of psychotherapy, Cuijpers et al. (2018) 
included CAU as appropriate controls. CAU is an appropriate control group if one is estimating 
whether psychotherapy is more effective than the various mental health treatments being given in 
routine care.  However, CAU typically contains a wide array of treatments (Spielmans, Gatlin, & 
McFall, 2010; Wampold et al., 2011), which was noted by Cuijpers et al.: “[CAU] is problematic 
since (sic) this varies considerably across settings and health care systems, making comparisons 
very heterogeneous” (p. 3).  Eysenck was making a claim that psychotherapy was not more 
effective than no treatment, not that it was not more effective than the usual care patients were 
receiving, which might well be psychotherapy or other mental health services.  Indeed in 
Cuijpers et al. CAU included credible treatments such as supportive psychotherapy or 
pharmacotherapy delivered by experienced therapists (Saloheimo et al., 2016); combination of 
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psychotherapy and pharmacotherapy according to Dutch Depression Guidelines (Wiersma, et. 
al., 2015), or antidepressant medication (Power & Freeman, 2012).  CAUs are often nearly as 
effective as first-line psychotherapeutic treatments for several disorders, including borderline 
personality disorder, anxiety, and depression (Cristea et al., 2017; Wampold et al., 2011).  
Comparisons to these relatively active treatments produces effects irrelevant to Eysenck’s claims 
about the effectiveness of psychotherapy vis-à-vis no treatment.  
 Other control group.  Cuijpers et al. (2018) included “other control groups” when 
estimating the “true” effect of psychotherapy.  They did not define what “other” controls were 
but we examined these studies and found that “other” treatment included pill placebos (e.g., 
Dimidjian et al., 2006, Elkin et al., 1989, Hegerl et al., 2010,), or “so called” psychological 
placebos (e.g. Armento, 2012, Losada et al., 2015, Spinelli & Endicott, 2003, Watt & Cappeliez, 
2000).  We know that pill placebo with clinical management is often quite effective, often as 
effective or nearly as effective as antidepressant medication, particularly for depression (Kirsch, 
2002, 2009, 2010; Kirsch et al., 2008).  Furthermore, psychological placebos are often quite 
effective (Baskin, Tierney, Minami, & Wampold, 2003; Honyashiki et al., 2014; Smits & 
Hofmann, 2009).  In any event, the use of pill placebo and psychological placebos addresses 
questions about the relative efficacy of psychotherapy compared to some relatively active 
controls, but does not address Eysenck’s claims about the effectiveness of psychotherapy in 
comparison to no treatment  
Definition of Psychotherapy 
 Cuijpers et al. (2018) made conclusions about psychotherapy, as evidenced by the subtitle 
of their article: “A reassessment of the effects of psychotherapy for adult depression.”  If one is 
to assess the effects of psychotherapy vis-à-vis the claims of Eysenck, then it is incumbent to 
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include only studies of psychotherapy.  However, Cuijpers et al. did not provide any description 
of inclusion and exclusion criteria for psychotherapy and many of the studies in Cuijpers et al. 
were clearly not psychotherapy. For example, in one study depressed patients were given a copy 
of a self-help book based on cognitive therapy and were “asked to read the book and to complete 
all the homework exercises in the book within 1 month” (Floyd, Scogin, McKendree-Smith, 
Floyd, & Rokke, 2004, p. 305).  In a similar study (van Bastelaar, Cuijpers, Pouwer, Riper, & 
Snoek, 2011) patients with diabetes and elevated depression symptoms were given access to a 
website with “eight lessons” (p. 51) on depression and diabetes. Lamers et al. (2010) investigated 
a “minimal psychological intervention” for elderly depressed patients delivered by “four nurses 
with no specific mental health expertise” (p. 219).  In Cuijpers et al. (2018) we counted at least 
61 effects derived from interventions that do not meet common definitions of psychotherapy 
(e.g., Wampold & Imel, 2015), including Eysenck’s (1961) definition, recreating the “apples and 
oranges” problem about which Eysenck was concerned.  At the very least, conclusions about 
psychotherapy are unjustified when interventions that are not psychotherapy are lumped with 
psychotherapeutic treatments. 
Western versus Non-Western Studies 
 Cuijpers et al. (2018) excluded non-Western studies (viz., those from Africa, Asia and 
Latin America) based on the finding that the effects of psychotherapy were greater in non-
Western countries. Cuijpers et al. (2018) did not define “Western” in a transparent manner (Latin 
America is in the Western hemisphere and Chile and Argentina are typically classified as 
“Western”) and provided no hypothesis-driven or theoretical reason to exclude evidence from 
some countries. Of course, excluding non-Western evidence created smaller effects.  Our re-
Psychotherapy     p. 14 
 
analyses suggested the Western/Non-western effect is at least partially due to outliers, which we 
omitted in our re-analysis (see below).     
Risk of Bias 
Cuijpers et al. (2018) further reduced the number of studies by excluding studies with 
“possible systematic errors … or deviations from the true or actual outcomes” (p. 3). It seems to 
us, however, that this reduction was conducted in a manner that discards relevant research 
studies. Specifically, “four items of the Cochrane risk of bias assessment tool” (p. 3) were used 
to define risk of bias and studies were excluded if any one of these four criteria were coded as 
negative or unclear.   
 Using only four of the six domains of the Cochrane risk of bias (RoB) tool, Cuijpers et 
al.’s (2018) definition did not cover a number of methodological aspects that are especially 
relevant for psychotherapy, possibly leading to the inclusion of studies with important deficits 
and to the exclusion of studies with appropriate methodology.  In short, Cuijpers et al. excluded 
the RoB domains blinding of participants and personnel and selective outcome reporting. 
Coding the first domain was considered “not possible” (p. 4) in the included studies and coding 
the latter was feared to result in “very few trials … with low risk of bias” (p. 4)—that is to say, 
all psychotherapy studies have significant risk of bias. Clearly, patients and therapists are always 
cognizant of the psychotherapy they are receiving (or not receiving) and therefore blinding is not 
possible. However, there is broad consensus in the Cochrane and the psychotherapy research 
communities that exactly because of this deviation from the ideal experiment it is important to 
pay attention to RoB dimensions capturing quality of care and expectations (e.g., treatment 
credibility, therapist allegiance, treatment integrity), which were ignored in Cuijpers et al.’s 
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study (see Baskin et al., 2003; Higgins & Green, 2011; Laird, Tanner-Smith, Russell, Hollon, & 
Walker, 2017; Munder & Barth, 2017).  
 One of the studies excluded by Cuijpers et al.’s (2018) definition of risk of bias is the 
NIMH Treatment of Depression Collaborative Research Program (Elkin et al., 1989), even 
though this was considered the most sophisticated and methodologically rigorous clinical trial of 
psychotherapy ever conducted.  In contrast, Cuijpers et al. included other studies that have 
important methodological shortcomings, including those with few therapists (Milgrom, Negri, 
Gemmill, McNeil, & Martin, 2005, with two therapists, and Burns et al., 2007 with one therapist) 
and several that did not monitor or assess adherence (e.g., Burns et al., 2007).  Allegiance, an 
important aspect in psychotherapy studies (Munder, Brütsch, Leonhart, Gerger, & Barth, 2013; 
Munder, Flückiger, Gerger, Wampold, & Barth, 2012; Munder, Gerger, Trelle, & Barth, 2011) 
was ignored even though many of the studies in this data set were conducted by advocates of one 
of the treatments.   
 There are other problems with the Cuijpers et al.’s RoB determination.  There are major 
discrepancies between the number of studies assigned to each risk category reported in Table 1 
and Appendix C of Cuijpers et al. (2018). No interrater agreement was reported.  Given these 
problems in Cuijpers et al.’s RoB determination, we did not use their ratings in our analysis.    
Our Estimate of the Effects of Psychotherapy 
 Professor Cuijpers, upon our request, provided the effect size estimators as well as their 
standard errors for all 369 comparisons.  First, we examined the three types of control groups 
separately using standard random-effects meta-analysis using the “metafor” package of the “R” 
statistical software (Viechtbauer, 2010).  In each case we omitted the outliers (13 WL, 2 CAU 
and 1 “Other control”) based on thresholds determined by visual inspection of the effect size 
Psychotherapy     p. 16 
 
distribution for each type of control and omitted comparisons for which g > 2.00. Removing such 
outliers reduces the estimate of the effectiveness of psychotherapy, compared to other 
procedures, such as Winsorization (Tukey, 1962), in which data is adjusted for outliers rather 
than eliminated entirely.  We also then adjusted the effects for publication bias using trim and fill 
R0-estimates within the “metafor” package.  
The results are shown in Figure 1, for all comparisons and those that involved 
psychotherapy.  As we have discussed here, the WL is the most appropriate control group for 
estimating the effects of psychotherapy compared to no treatment.  As can be seen in Figure 1, 
the effect of treatment versus wait list is 0.71 (SE = 0.03), a statistically conservative estimate, 
given elimination of outliers and correcting for publication bias, and one which is similar to that 
determined by Smith and Glass (1977) and many others (see Wampold & Imel, 2015).  
 Because we wanted to restrict conclusions to psychotherapy, as defined by Eysenck, for 
the treatment of adult patients diagnosed with depression, we trimmed the data set accordingly. 
There were 270 comparisons that met definition of psychotherapy (either individual or group), of 
theses 112 contained adults (excluding elderly, students, patients with general medical conditions 
or women with post-partum depression) and finally 71 comparisons that involved a diagnosis of 
depression. The effects for these 71 comparisons (30 WL, 29 CAU, and 12 “Other control”), 
after correcting for publication bias, are also presented in Figure 1 (the standard errors are larger 
for the psychotherapy studies due to smaller sample sizes).  The SMD for psychotherapy versus 
WL in this set of comparisons was 0.75 (SE = 0.09), again confirming that psychotherapy is 
effective compared to no treatment, with a magnitude in the neighborhood of what Smith and 
Glass (1977) found.  Note, as well, that in this set of comparisons of treatments that were 
actually psychotherapy for adult patients diagnosed with depression, psychotherapy was 
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significantly superior to CAU (Hedges’ g = 0.31, SE = 0.11) and other control groups (Hedges’ g 
= 0.43, SE = 0.09). 
We also tested the set of psychotherapy comparisons to see if there were differences 
among treatments.  We used Cuijpers et al.’s (2018) coding and found that there were no 
statistically significant differences among different types of psychotherapy for adult patients 
diagnosed with depression (adding type of treatment to a meta-regression model with type of 
control did not significantly increase model fit, Likelihood ratio test = 9.888, p = .195). This 
result is consistent with Cuijpers et al. and contradicts Eysenck’s claims about the superiority of 
behavioral treatments. 
There are some methodological limitations that may or may not impact the results of the 
present meta-analysis. First, face-to-face interventional studies are conducted in super-nested 
designs, randomization procedures (as one of the key methods to handle risk of biases for 
internal validity) usually randomize patients to treatment conditions but therapists are neither 
randomly selected nor randomized to condition, which may impact the generalizability of the 
study results to therapists that are not investigated in the study conditions (e.g., Wampold & 
Imel, 2015). Second, there were unsolved discrepancies between the main text and the Appendix 
of Cuijpers et al. (2018) with regard to RoB criteria, which call into question the reliabilities of 
the RoB evaluations, further compounding the fact that rater procedures and rater agreement was 
not reported (see Armijo-Olivo et al., 2014; Hartling et al., 2012).  Thus, quality of studies was 
not considered in our re-analysis.  Third, although more statistical driven outlier definitions 
could have been applied (e.g., Viechtbauer & Cheung, 2010), we opted to use exclude outliers 
based on visual inspection of effect size distribution. This had the advantage of being consistent 
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with Cuijpers et al., who used the same definition of outliers. Fourth, we did not independently 
calculate effect sizes but used instead the effects provided by Cuijpers et al. (2018).  
Conclusion 
After removing outliers, correcting for publication bias, using wait-list control groups, 
and restricting analysis to psychotherapy studies, the results of our analyses reveal that 
psychotherapy for depression is demonstrably effective compared to no treatment.  Indeed, the 
effect size for psychotherapy compared to natural history, as estimated using WL controls, is 
about the same size as is generally accepted (i.e., in the neighborhood of 0.70).  As well, 
psychotherapy, as implemented in these studies, was superior to care-as-usual, even when such 
care was often credible alternative treatments, and superior to relatively effective “other control 
groups”.   
The discrepancy between our results and Cuijpers et al.’s (2018) is due in large part to 
what is considered an appropriate control group for determining the effectiveness of 
psychotherapy.  Eysenck’s claims were about the effectiveness of psychotherapy related to the 
natural history of the disorder.  Determining natural history within the context of randomized 
clinical trials of psychotherapy is impossible but we have made a case that WL controls are the 
best possible solution for testing the particular conjecture put forth by Eysenck.  Furthermore, 
dismissing WL conditions as biased is not supported by evidence and WL is preferable to other 
controls that involve some form of treatment as a means to estimate mental health status without 
treatment.  In any case, psychotherapy is more effective than care-as-usual, even when such care 
is quite credible, and is more effective than “other control groups” as defined by Cuijpers et al. 
(2018).   
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Given these results, as well as a considerable corpus of evidence consistent with these 
results (Wampold & Imel, 2015), we argue that the field should accept the general conclusion 
that psychotherapy is an effective practice and give our attention to ways that psychotherapy 
could be improved.   
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Figure caption 
Figure 1. Effect sizes for psychological interventions for depression. Error bars represent 
standard errors. PT = Psychotherapy. Overall is based on all effect sizes without outliers and 
corrected for publication bias (k = 146 contrasts with wait list, k = 142 contrasts with care as 
usual, k = 65 contrasts with "other" controls). PT for adult depression only includes (individual 
or group) psychotherapy for adults with a diagnosis of depression (k = 30 contrasts with WL, k = 
29 contrasts with care as usual, k = 12 contrasts with “other control”).
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